Together with diet and behavioural modi®cation, regular exercise is one of the key components of programs for the treatment of obesity. It appears to be one of the major factors determining the long-term success of weight loss programs. One of the mechanisms that may underlie this and other bene®cial effects of regular exercise is the effect of exercise training on substrate utilisation. Exercise training increases fat oxidation in lean subjects. The capacity to mobilise and oxidise fat has been shown to be impaired in obese and post-obese subjects. Thus, an increase in the capacity for fat oxidation may help to maintain fat and energy balance at a lower fat mass in individuals with a predisposition for obesity. However, in view of the impaired fat oxidation in obese and post-obese individuals the question arises whether exercise training also increases fat oxidation in the obese. Few studies have addressed this question and have investigated the effect of exercise training on substrate utilisation in obesity. Addition of an exercise training program has been shown to prevent the reduction of basal fat oxidation that is associated with dietinduced weight loss in two studies. No effect of additional exercise training on substrate oxidation during exercise was found. In post-obese subjects exercise training caused no change in 24 h substrate oxidation in one study and increased carbohydrate, rather than fat oxidation in another. In obese subjects neither low (40% maximal aerobic ®tness (VO 2 max)) nor high (70% VO 2 max) intensity training was found to affect resting substrate oxidation. During exercise fractional fat oxidation was increased after low, but not after high intensity training. The question, whether exercise training increases fat oxidation in obese and post-obese as in lean subjects therefore cannot be answered conclusively at this point in time and requires further study. The role of exercise intensity and type of exercise needs to be studied as well.
Introduction
For many years regular exercise has been recommended as an important strategy in the prevention and management of obesity. Together with diet and behavioural modi®cation, regular exercise is one of the key components of programs for the treatment of obesity.
1 Although the weight loss due to exercise alone is rather small, 2 ± 4 certainly in comparison with the weight loss that can be attained by restriction of dietary energy intake, regular exercise appears to be one of the major factors determining the long-term success of weight loss programs.
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Apart from its effects on body weight and body composition, regular exercise has many other potential bene®ts in overweight individuals: cardiorespiratory and muscle ®tness may increase, insulin sensitivity may improve, 11 ± 13 blood pressure may be reduced, 14 blood lipid pro®le may improve, 13, 15, 16 and psychological well-being may increase. 17 Moreover, a high level of cardiorespiratory ®tness, usually associated with the performance of regular exercise, appears to provide protection against the force of mortality predictors such as smoking, elevated blood pressure and high body mass index (BMI). 18 Exercise also has certain risks, of which musculoskeletal injuries occur most frequently and sudden death is the most serious, but fortunately occurs rather infrequently. If proper precautions are taken, the bene®ts of exercise in general outweigh the risks. 19, 20 One of the mechanisms that may underlie some of the bene®cial effects of regular exercise in obesity is the effect of exercise training on substrate utilisation. The composition of the fuel mix oxidised and the rate of fuel oxidation are mainly determined by energy requirements, energy balance and the dietary macronutrient composition, lean body mass, fat mass and aerobic capacity. Exercise enhances substrate oxidation in the largest body compartment and the one most capable of using fatty acids for energy generation, that is, skeletal muscle. 21 Moreover, exercise training increases fat oxidation at rest as well as during exercise in lean subjects. An increased capacity to oxidise fat may help to maintain fat balance (and thus energy balance) at a lower fat mass in individuals with a predisposition for obesity. 21, 22 Substrate utilisation in obesity Several lines of evidence indicate that subjects who develop obesity may have an impaired fat oxidation, so that they need a higher fat mass at a certain dietary fat intake to maintain fat balance than subjects with normal fat oxidation.
A study of Pima Indians from Arizona, a population with a high prevalence of obesity and type II diabetes, has shown that a high 24 h respiratory quotient (RQ), indicative of relatively low fat oxidation, is predictive of future weight gain. 23 In this study, diet was controlled for two days prior to the 24 h RQ measurements. Adjustments were made for % body fat and energy balance. 24 h RQ has been shown to be higher in the post-obese women than in the non-obese women of several studies, although these studies were not fully controlled for factors that may affect substrate oxidation. 24 ± 26 In a well-controlled study, Ranneries et al 27 showed that fat oxidation and % of total energy expenditure from fat oxidation at rest and during recovery from exercise were signi®cantly lower in formerly obese women than in control women. However, during exercise at approximately 50% of maximal aerobic ®tness (VO 2 max) no differences in fat oxidation or % energy from fat oxidation were found between the groups.
Several studies have also investigated the effect of weight loss by energy restricted diets on substrate utilisation in obese subjects. Ballor et al 28 did not ®nd an effect of an average 9 kg weight loss in obese men and women on % energy derived from fat under resting conditions, after one week on a weight maintenance diet. After a high fat meal, however, this parameter was signi®cantly reduced after weight loss. Schutz et al 29 reported a signi®cant fall in fasting fat oxidation in obese postmenopausal women who were on a weight maintenance diet for 10 days after an average 12.7 kg weight loss. Preliminary data from our laboratory suggest that a 10 kg weight loss increases fasting and exercise RQ in obese men under weight-stable conditions (Van Aggel-Leijssen, Saris and Van Baak, unpublished data).
The above-mentioned studies all suggest that a low capacity for fat oxidation, re¯ected by a high fasting, 24 h or post-absorptive RQ, may be involved in the aetiology of obesity.
The mechanism of the reduced capacity for fat oxidation is not clear. The oxidation of plasma free fatty acids (FFA), which is the major source for fatty acid oxidation under most circumstances, is in¯uenced by blood fatty acid concentration; capillary density; blood¯ow; transport capacity across the blood vessel wall and tissue cell membranes; mitochondrial capacity to take up and oxidise fatty acids; and neural and hormonal factors. Recent studies suggest that the intracellular availability of glucose may be the most important factor determining the substrate mix that will be oxidised. 30 Several mechanisms, involving one or more of these factors, have been put forward to explain the reduced fat oxidation in individuals at risk of body weight gain, in post-or reduced-obese and obese individuals.
Adipose tissue lipolysis and rate of appearance of fatty acids Hellstro Èm et al 31 reported in vitro lipolytic resistance to catecholamines, at least partly due to impaired function of hormone-sensitive lipase, in abdominal subcutaneous fat cells of non-obese subjects with a family trait for obesity (at least one of the ®rst-degree relatives having a body mass index (BMI) of 27 kgam 2 or more). The b-adrenoceptor numbers and sensitivity appeared to be normal and basal lipolysis per cell was similar in the two groups. Reynisdottir et al 32 on the other hand, found a 10-fold decreased lipolytic sensitivity to the non-selective b-adrenoceptor agonist noradrenaline per cell in abdominal subcutaneous fat cells from upper body obese women compared to nonobese women, due to a lower density of b 2 -adrenoceptors. Basal lipolysis per cell was higher in upper body obese than in lean women. In another study weight loss was shown to improve the lipolytic sensitivity of adipocytes to b 2 -adrenoceptor stimulation and to reduce basal lipolysis in upper body obese women. 33 However, this improved sensitivity was not related to increases in b 2 -adrenoceptor density. A reduction of the activity of hormone-sensitive lipase appeared to be involved in the reduction of basal lipolysis. 33 This study suggests that the increased basal lipolysis and the reduced responsiveness of upper body obese women to b 2 -adrenoceptor stimulation can be reversed by weight loss and thus are unlikely to be involved in the aetiology of obesity. Indirect evidence for a reduced lipolytic responsiveness to b 2 -adrenoceptor stimulation in obesity also comes from in vivo studies, which have demonstrated a reduced plasma FFA response to the infusion of the non-selective b-adrenoceptor agonist isoprenaline and the b 2 -selective adrenoceptor agonist salbutamol, but not to infusion of dobutamine, a b 1 -selective adrenoceptor agonist, in obese men. 34 ± 36 In these men weight loss did not affect the reduced isoprenaline-induced FFA response, 37 suggesting that the reduction was not the consequence of an increased fat mass. The apparent discrepancy between the result of Reynisdottir et al and Blaak et al may be due to differences between in vitro and in vivo responses, as was suggested by Lillioja et al. 38 In Pima Indian women with BMIs ranging from 19±49 kgam 2 these investigators found that basal fat cell lipolysis (expressed per cell, cell surface area or kg fat mass) was positively correlated with % body fat or fat mass. However, in vivo whole body FFA rate of appearance did not increase proportionally, so that the ratio between FFA rate of appearance and lipolysis decreased with increasing % body fat. Lillioja et al suggest that this may be due to the hormonal milieu in vivo or the distance to and¯ow through the capillaries. 38 For instance, differences in catecholamines, insulin and adenosine concentrations, and adipose tissue blood¯ow between lean and obese have been reported. 32 Figure 1 ). Also the response of the glycerol and FFA rates of appearance per kg fat mass to adrenaline infusion is signi®cantly blunted in the obese. 42, 43 Since there was no difference in the adrenaline-stimulated rate of appearance of FFA when expressed per kg lean body mass between lean and obese, 42, 43 Wolfe et al 42 suggested that the blunted response in obese subjects may simply re¯ect the decreased demand to meet the energy requirements of the lean body mass. Unfortunately, the effect of weight loss on the rate of appearance of FFA in obesity has not yet been studied.
Fatty acid delivery and transport
Sources of fatty acids that are delivered to the tissues via the blood are FFA, complexed with albumin, chylomicrons and very low density lipoproteins (VLDL). The FFA in the blood, before binding to albumin, are mainly released from the body's adipose tissue. 44 Arterial FFA concentration and in¯ow (¯ow Â concentration) have been shown to be strongly coupled to leg FFA uptake at rest and during exercise. 45, 46 Lipoprotein lipase, which is attached to the luminal surface of the endothelial cells, hydrolyses the triacylglycerol core of chylomicrons and VLDL. The transport of FFA across the endothelial cells and into the tissue cells is protein-mediated, and in skeletal muscle fatty acid binding protein (FABP) is crucial for the transport of FFA across the sarcoplasma. 47 The rate of fatty acyl-CoA synthesis in the cytosol has to be high in order to maintain the fatty acid concentration gradient from blood to muscle that appears to be the major driving force for net FFA uptake. 44 The transport of fatty acyl-CoA across the mitochondrial membrane is mediated by camitine palmitoyltransferase 1 (CPT 1). The activity of CPT 1 is regulated by malonyl-CoA, a potent inhibitor of CPT 1 activity. 48 How much FFA can be oxidised in the mitochondria depends on mitochondrial density, activity of the enzymes of the b-oxidation and the rate of oxidation of acetyl-CoA generated by the boxidation, which depends on the energy requirements of the muscle cell. 48 In obesity, several of the processes involved in FFA delivery, uptake and utilisation may be affected. Although resting arterial FFA concentration is usually higher in obese than lean subjects, the increase upon stimulation is often reduced, resulting in similar or even lower FFA concentrations in the obese. 34, 42, 43 Total and forearm skeletal muscle blood¯ow has been shown to be similar in lean and obese subjects at rest, but adrenaline-or isoprenaline-induced increases in blood¯ow were blunted in the obese. 34, 43 Weight loss did not normalise the blunted FFA and blood¯ow response. 37 These data suggest that under certain stimulated conditions, but not at rest, delivery of FFA via the blood to muscle, may be lower in obese than in lean individuals and that this does not tend to normalise with weight loss.
Very few data exist on lipoprotein lipase (LPL) activity in obesity, and most of it concerns adipose tissue LPL activity. Fasting adipose tissue LPL activity is increased in obesity and may increase even further after weight loss. 49 The few data on skeletal muscle LPL (smLPL) in obesity are not consistent. Eckel et al 50 found no difference in fasting smLPL in lean and moderately obese women, but after sustained weight loss smLPL was signi®cantly reduced. However, Astrup et al 51 mention that smLPL is similar in post-obese women and matched controls. Thus for the moment it remains unclear whether skeletal muscle LPL activity plays a role in the impaired fat oxidation associated with obesity.
No data on fatty acid binding protein content and malonyl-CoA in (post-)obese skeletal muscle are available at this moment, so it is unknown whether FFA transport across membranes and cytosol, and into the mitochondria, plays a role in determining fat oxidation in obesity.
Oxidative potential
Data on the relationship between oxidative potential, re¯ected in muscle ®bre type and oxidative enzyme activities, and obesity, are con¯icting. Wade et al 52 demonstrated a negative association between body fat and proportion of type 1 muscle ®bres, which could not be reproduced by others. 9, 53 Other investigators found that increased BMI was associated with increased % (glycolytic) type IIb ®bres and reduced % (oxidative) type IIa ®bres. 54, 55 Also malate dehydrogenase, a marker enzyme for the tricarboxylic acidcycle, but not 3-hydroxyacyl CoA dehydrogenase (HADH), a marker enzyme for the fatty acid b-oxidation, activity was found to correlate negatively with body fat. 53 Kempen 9 found no change in muscle ®bre type distribution after an 11 kg weight loss in obese Training and obesity MA van Baak et al S13 women. Astrup et al 51 report a comparable muscle ®bre type distribution in post-obese and lean control women, but a reduced HADH activity in the postobese women. Therefore, the role of ®bre type and oxidative capacity in obesity is not clear at the moment and deserves further study.
Availability of glucose
It is generally accepted that the availability of FFA will dictate fat oxidation by the skeletal muscle, as predicted by the Randle cycle. However, Wolfe 30 recently challenged this concept and proposed that the main factor regulating the level of oxidation of fatty acids is not the availability of FFA, but rather the intracellular availability of glucose. Superimposed upon this regulatory effect of glucose availability is the mass effect of FFA availability.
Skeletal muscle glucose uptake tends to be higher in obese than in lean subjects and this does not change with weight loss. 34, 37, 56 Mandarino et al 56 showed that at comparable arterial glucose concentration and higher arterial FFA concentration, leg glucose uptake and oxidation are signi®cantly higher in obese than in lean subjects. However, this does not exclude the possibility that glucose uptake is increased because of an impaired FFA uptake by the muscle.
Flatt 21, 57 has proposed a model predicting that increased glycogen stores will favour carbohydrate oxidation and limit fat oxidation and will promote increase in fat mass on a diet with a relatively high fat content. Flatt 57 suggests that a gradual increase of the range within which glycogen concentrations are habitually maintained may be related to the increased prevalence of obesity. In support of this concept are data from Schrauwen et al, 58 showing that the adaptation to a high fat diet is more rapid when muscle glycogen stores are lowered by exhaustive exercise, indicating that fat oxidation can be increased more easily when glycogen stores are low. No data on habitual glycogen stores to support this concept are available at the moment. A recent study in a small number of lean and obese surgical patients demonstrated that liver glycogen stores after an overnight fast were signi®cantly higher in the obese subjects. However, the increased liver glycogen content in obese patients was not associated with increased hepatic glucose production and liver glycogenolysis was reduced. 59 Exercise training and substrate utilisation in lean subjects Regular exercise is known to cause a progressive reduction of the utilisation of muscle glycogen and blood glucose and a progressive increase in fat utilisation, during exercise. 60 ± 65 Most of the increased fat oxidation in trained individuals appears to come from oxidation of FFA derived from intramuscular triacylglycerol stores, while adipose tissue lipolysis is reduced.
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The effects of training on non-exercise substrate utilisation are less consistent than those during exercise. Often an increased fat oxidation is found during recovery from an exercise bout. 68, 69 Cross-sectional studies that measured substrate oxidation at least 24h after the last exercise bout have shown higher as well as similar fasting RQ when comparing trained and untrained individuals. 22 Longitudinal studies have demonstrated increased fasting fat oxidation after exercise training in young and elderly normal weight individuals. 70, 71 Increases in skeletal muscle content of mitochondria, enzymes involved in activation, transfer into mitochondria and b-oxidation of fatty acids, increases in fatty acid-binding protein content, smLPL activity, and intramuscular triacylglycerol stores, and changes in the activity of regulatory molecules such as malonyl-CoA, occur with training and favour fat utilisation. 47, 72, 73 Cross-sectional and longitudinal studies indicate that endurance exercise training increases lipolytic responsiveness to catecholamines of adipocytes. 74 ± 79 Since the density of receptors does not appear to change with training, the increased responsiveness appears to be a post-receptor adaptation, probably at the level of hormone-sensitive lipase. 80 An in vivo microdialysis study did not provide evidence for increases in basal and epinephrine-induced glycerol release from subcutaneous abdominal adipose tissue in trained individuals. 81 In longitudinal training studies, both increased (in young subjects) and unchanged (in elderly subjects) fasting rates of appearance of FFA after training have been found. 70, 71 Exercise training and substrate utilisation in obesity Although many studies have investigated the effects of exercise training in obesity, remarkably few have looked at the effects of training on substrate utilisation.
Svendsen et al 82 compared the RQ during exercise at 30 W in overweight postmenopausal women after a 12 week dietary intervention and a dietary plus exercise training intervention, when subjects had returned to a weight stable condition. Weight loss was similar in the two groups, but fat loss was higher in the exercise training group. In both groups RQ was lowered after the intervention, but there was no difference between groups. Only in the exercise training group was VO 2 max signi®cantly increased. Nicklas et al 83 showed that basal fat oxidation was On the other hand, Kempen et al 84 showed that fat oxidation during exercise at 45% VO 2 max was increased in obese women after an eight week combined diet and exercise training intervention compared to the dietary intervention alone. However, in this study the subjects were still in negative energy balance at the time of the post-intervention measurements. Lower glycogen stores in the exercise group under these conditions may have been responsible for this ®nding.
Buemann et al 85 found no effect of training on the 24 h RQ on post-obese women, measured in a respiration chamber. In weight reduced obese men, a 12 month exercise training intervention even appeared to increase the 24 h RQ. 10 However, in this study diet was only controlled during the respiration chamber measurement and changes in habitual diet during the intervention may have biased the outcome. Nevertheless, these ®ndings may suggest that exercise training is not able to increase 24 h fat oxidation in individuals with a predisposition towards obesity. The only information on the effect of training on 24 h RQ in lean subjects comes from a study by Treuth et al 86 in older women. A 16 week strength training program reduced the 24 h nonprotein RQ in a respiration chamber for this group of lean older women. The investigators suggest that the increase in fat oxidation was related to the increase in fat free mass, due to strength training.
In another study we investigated the effect of exercise training alone on substrate utilisation in obese men. 87 Three groups of obese men were studied over a 12 week period: a control group that did not change physical activity during the experimental period: a low-intensity training group that exercised three times per week at 40% VO 2 max for 1 h; and a high-intensity training group which exercised three times per week at 70% VO 2 max for 30 min. Total energy expenditure of each exercise session was comparable in these two groups. Body weight and body composition did not change in any of the groups, so it is possible to study the effects of exercise training without interference of weight loss. Only in the high intensity training group was the VO 2 max increased. Fasting fat oxidation, as determined by indirect calorimetry, did not change in any group. RQ during cycle ergometry at 50% of pre-intervention VO 2 max was lowered in all three groups, but the reduction was signi®cantly more pronounced in the low intensity training group. The fat oxidation response to b-adrenoceptor stimulation by infusion of the b-adrenoceptor agonist isoprenaline, was unchanged in all groups, indicating that an increased in vivo response to badrenoceptor stimulation was probably not involved in this effect. 87 
Conclusion
In summary, the data presented above do not give a clear answer to the question whether exercise training increases fat utilisation at rest, during exercise or over 24 h in obese subjects. Further studies are clearly needed. 
